{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:54:33Z","timestamp":1783392873733,"version":"3.54.6"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Deliv."],"abstract":"<jats:p>Synthetic polymer microparticles (SPMs), commonly referred to as microplastics, are subject to increasing restrictions due to their environmental persistence and uncertainty about potential human health effects. These substances are regulated under Regulation (EC) No 1907\/2006 (REACH). Commission Regulation (EU) 2023\/2055 amends REACH by introducing a restriction on SPMs in Annex XVII, including phased information and reporting obligations for in-scope uses. Although medicinal products are derogated from the market ban, these obligations have practical implications for pharmaceutical supply chains. Medicinal products containing SPMs are subject to specific reporting obligations under the REACH regulation. These obligations apply when the excipients meet the SPM definition and cannot be excluded based on criteria such as being naturally occurring, or due to their solubility or demonstrated degradability. This paper presents an operational decision-making framework that interprets the EU REACH restriction on SPM for pharmaceutical excipients and drug-delivery systems. The framework integrates regulatory definitions with testing strategies, supplier qualification processes, and downstream compliance workflows. An industry case example illustrates a combined approach using portfolio screening and biodegradation testing. This can generate evidence to support compliance decisions while preserving formulation performance.<\/jats:p>","DOI":"10.3389\/fddev.2026.1854462","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:35:06Z","timestamp":1780551306000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Microplastics matter: practical implications of the EU REACH restriction for the pharmaceutical industry"],"prefix":"10.3389","volume":"6","author":[{"given":"Pauline Henrica Maria","family":"Janssen","sequence":"first","affiliation":[{"name":"DFE Pharma GmbH & Co. KG, Innovation and Technical Services","place":["Goch, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem Antoon","family":"Rijpkema","sequence":"additional","affiliation":[{"name":"DFE Pharma GmbH & Co. KG, Innovation and Technical Services","place":["Goch, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorina","family":"Bisharat","sequence":"additional","affiliation":[{"name":"DFE Pharma GmbH & Co. KG, Innovation and Technical Services","place":["Goch, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlijn","family":"Orbons","sequence":"additional","affiliation":[{"name":"DFE Pharma GmbH & Co. KG, Innovation and Technical Services","place":["Goch, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Jaspers","sequence":"additional","affiliation":[{"name":"DFE Pharma GmbH & Co. KG, Innovation and Technical Services","place":["Goch, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan Hendricus Jozef","family":"Dickhoff","sequence":"additional","affiliation":[{"name":"DFE Pharma GmbH & Co. KG, Innovation and Technical Services","place":["Goch, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"104901","DOI":"10.1016\/j.ebiom.2023.104901","article-title":"The potential impacts of micro- and nanoplastics on various organ systems in humans","volume":"99","author":"Ali","year":"2024","journal-title":"eBioMedicine"},{"key":"B2","first-page":"1055","article-title":"Polymeric excipients in pharmaceutical formulations: a comprehensive review","volume":"9","author":"Arun","year":"2024","journal-title":"Int. J. Pharm. Res. Appl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"141298","DOI":"10.1016\/j.chemosphere.2024.141298","article-title":"Analysis of environmental biodegradability of cellulose-based pharmaceutical excipients in aqueous media","volume":"352","author":"Bading","year":"","journal-title":"Chemosphere"},{"key":"B4","doi-asserted-by":"publisher","first-page":"143739","DOI":"10.1016\/j.chemosphere.2024.143739","article-title":"Assessing the aquatic biodegradation potential of polymeric excipients for pharmaceutical formulation","volume":"368","author":"Bading","year":"","journal-title":"Chemosphere"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103261","DOI":"10.1016\/j.jddst.2022.103261","article-title":"Technical insight into potential functional-related characteristics (FRCs) of sodium starch glycolate, croscarmellose sodium and crospovidone","volume":"70","author":"Berardi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.xphs.2022.04.016","article-title":"A nitrite excipient database: a useful tool to support N-Nitrosamine risk assessments for drug products","volume":"112","author":"Boetzel","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"B7","volume-title":"Materials Science and Engineering: An Introduction","author":"Callister","year":"2018"},{"key":"B8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s44274-025-00402-8","article-title":"Exploring microplastic pollution from origin to environmental impact and remediation approaches","volume":"3","author":"Choudhary","year":"2025","journal-title":"Discov. Environ."},{"key":"B9","unstructured":"New EU restrictions on microplastics in cosmetic products\n          \n          \n            \n              Coslaw\n              E.\n            \n          \n          \n          2023"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1039\/D0EW00776E","article-title":"Influence of short- and long-term exposure on the biodegradation capacity of activated sludge microbial communities in ready biodegradability tests","author":"Dalmijn","year":"2021","journal-title":"Environ. Sci. Water Res. and Technol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/jps.24299","article-title":"Excipient variability and its impact on dosage form functionality","volume":"104","author":"Dave","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"B12","volume-title":"How to Prepare a Microplastics Report","year":"2025"},{"key":"B13","unstructured":"Environment: microplastics"},{"key":"B14","article-title":"Commission regulation (EU) 2023\/2055 of 25 September 2023 amending Annex XVII to regulation (EC) No 1907\/2006 of the European Parliament and of the Council concerning the REACH as regards synthetic polymer microparticles","year":"","journal-title":"Official J. Eur. Union"},{"key":"B15","volume-title":"Annex XVII to REACH - Conditions of Restriction Entry 78","year":""},{"key":"B16","article-title":"REACH restriction of synthetic polymer microparticles","volume-title":"Explanatory Guide Part III - Annexes","year":""},{"key":"B17","article-title":"Microbeads in toiletries regulations","year":"2017","journal-title":"Environ. Clim. Change Can. Ott"},{"key":"B18","volume-title":"The Cosmetics Rules","year":"2020"},{"key":"B19","first-page":"17","article-title":"Microcrystalline cellulose: the inexhaustible treasure for pharmaceutical industry","volume":"4","author":"Hindi","year":"2017","journal-title":"Nanosci. Nanotechnol. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1897\/1552-8618(1984)3[551:irfbto]2.0.co;2","article-title":"Interpreting results from biodegradability tests of chemicals in water and soil","volume":"3","author":"Howard","year":"1984","journal-title":"Environ. Toxicol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.15376\/biores.20.1.hubbe","article-title":"Biodegradability of cellulose fibers, films, and particles: a review","volume":"20","author":"Hubbe","year":"2025","journal-title":"BioResources"},{"key":"B22","volume-title":"IPEC Best Practices Guide for European REACH Restriction on Synthetic Polymer Microparticles (SPM) for Pharmaceutical Excipients","year":"2025"},{"key":"B23","doi-asserted-by":"publisher","first-page":"114803","DOI":"10.1016\/j.ejpb.2025.114803","article-title":"Quantifying cross-linking strength in sodium starch glycolate and its impact on tablet disintegration and dissolution","volume":"214","author":"Janssen","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s1461-5347(99)00237-0","article-title":"An overview of the different excipients useful for the direct compression of tablets","volume":"3","author":"Jivraj","year":"2000","journal-title":"Pharm. Sci. and Technol. Today"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1038\/s41591-025-03902-5","article-title":"Health impacts of microplastic and nanoplastic exposure","volume":"31","author":"Lamoree","year":"2025","journal-title":"Nat. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/environments13030134","article-title":"Unraveling microplastics: sources, environment and health impacts, and detection techniques","volume":"13","author":"Li","year":"2026","journal-title":"Environments"},{"key":"B27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11367-022-02040-1","article-title":"Methodology to address potential impacts of plastic emissions in life cycle assessment","volume":"27","author":"Maga","year":"2022","journal-title":"Int. J. Life Cycle Assess."},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.56770\/jcp2021515","article-title":"Review article: sodium starch glycolate as superdisintegrant","volume":"5","author":"Manzoor","year":"2021","journal-title":"J. Contemp. Pharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12302-023-00769-6","article-title":"Are ready biodegradation tests effective screens for non-persistence in all environemntal compartments?","volume":"35","author":"Martin-Aparicio","year":"2023","journal-title":"Environ. Sci. Eur."},{"key":"B30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/978-3-319-20206-8_18","article-title":"Addressing excipient variability in formulation design and drug development","volume-title":"Excipient Applications in Formulation Design and Drug Delivery","author":"Narang","year":"2015"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microplastics5010008","article-title":"Microplastics and human health: a comprehensive review on exposure pathways, toxicity, and emerging risks","volume":"5","author":"Nayak","year":"2026","journal-title":"Microplastics"},{"key":"B32","volume-title":"OECD Guideline for the Testing of Chemicals","year":""},{"key":"B33","volume-title":"Test No. 301: Ready Biodegradability","year":""},{"key":"B34","volume-title":"Management of Pharmaceutical Household Waste: Limiting Environmental Impacts of Unused or Expired Medicine","year":"2022"},{"key":"B35","volume-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2012"},{"key":"B36","first-page":"12","article-title":"Evaluation of biodegradability characteristics of cellulose-based film as per IS\/ISO 14855-1","volume":"11","author":"Saha","year":"2019","journal-title":"J. Appl. Packag. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1081\/pdt-120005731","article-title":"Multiple sources of sodium starch glycolate NF: evaluation of functional equivalence and development of standard performance tests","volume":"7","author":"Shah","year":"2002","journal-title":"Pharm. Dev. Technol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1021\/acsestwater.4c00316","article-title":"Defining primary and secondary microplastics: a connotation analysis","volume":"4","author":"Song","year":"2024","journal-title":"ACS ES&T Water"},{"key":"B39","volume-title":"Determination of Plastic Microbeads in Cosmetics (\u5316\u5986\u54c1\u4e2d\u5851\u6599\u5fae\u73e0\u7684\u6d4b\u5b9a)","year":"2021"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10311-024-01727-1","article-title":"Health risk of human exposure to microplastics: a review","volume":"22","author":"Tang","year":"2024","journal-title":"Environ. Chem. Lett."},{"key":"B41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/acs.estlett.2c00811","article-title":"Increasing the environmental relevance of biodegradation testing by focusing on initial biodegradation kinetics and employing low-level spiking","volume":"10","author":"Tian","year":"2023","journal-title":"Environ. Sci. and Technol. Lett."},{"key":"B42","volume-title":"The Environmental Protection (Microbeads) (England) Regulations 2017","year":"2017"},{"key":"B43","volume-title":"Resolution UNEP\/EA.5\/RES.14: End Plastic Pollution: Towards an Integnerationally Legally Binding Instrument","year":"2022"},{"key":"B44","volume-title":"Microbead-Free Waters Act of 2015","year":"2015"},{"key":"B45","volume-title":"Inactive Ingredient Database (IDD)","year":"2026"},{"key":"B46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10837450600561281","article-title":"The influence of product brand-to-brand variability on superdisintegrant performance: a case study with croscarmellose sodium","volume":"11","author":"Zhao","year":"2006","journal-title":"Pharm. Dev. Technol."}],"container-title":["Frontiers in Drug Delivery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddev.2026.1854462\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:35:13Z","timestamp":1780551313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddev.2026.1854462\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":46,"alternative-id":["10.3389\/fddev.2026.1854462"],"URL":"https:\/\/doi.org\/10.3389\/fddev.2026.1854462","relation":{},"ISSN":["2674-0850"],"issn-type":[{"value":"2674-0850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"article-number":"1854462"}}